We narrowed to 6 results for: pme i

...Friedman, N., Brown, T. M., Lipscombe, D., Moore, C. I., Hochgeschwender, U., & Shaner, N. C. (2024). Efficient..., J. M., Gautam, D., Scarselli, M., Ruiz de Azua, I., Li, J. H., Rosemond, E., Ma, X., Gonzalez, F. J....., Mimura, K., English, J. G., Liu, J., Inoue, K. I., Kumata, K., Seki, C., … Minamimoto, T. (2020). Deschloroclozapine..., L. M., Lambert, G. G., Lipscombe, D., Moore, C. I., Shaner, N. C., & Hochgeschwender, U. (2024). Engineering...attractive targets for development into chemogenetic tools. Studies of GPCRs led to development of mutated receptors...

...Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996). In vivo gene delivery and... H., Yu, E. Y., An, D. S., Sabatini, D. M., Chen, I. S., Hahn, W. C., Sharp, P. A., Weinberg, R. A., &....2192803 PMID: 12649500 Timms, R. T., Tchasovnikarova, I. A., & Lehner, P. J. (2018). Differential viral accessibility...understand integration sites have led to the development of multiple genome-wide analysis pipelines to...barcoding libraries . Mouse Modeling Since the development of safer lentiviral vectors, they have been seen...differences. Molecular Therapy — Methods & Clinical Development , 21 , 451–465. https://doi.org/10.1016/j.omtm...sites. Molecular Therapy — Methods & Clinical Development , 20 , 792–800. https://doi.org/10.1016/j.omtm...

...Ramakrishnan, C., Mattis, J., Prakash, R., Diester, I., Goshen, I., Thompson, K. R., & Deisseroth, K. (2010). ...Davidson, T. J., O'Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., Stehfest, K., Fudim... novel ChRs from other algal species and the development of synthetic variants to enhance the functionality...channelrhodopsin variants: features, limitations and future developments. Exp Physiol, 96 (1), 19–25. https://doi.org...

....2022.12.006 PMID: 36620071 Mirow, M., Schwarze, L. I., Fehse, B., & Riecken, K. (2021). Efficient pseudotyping...lead to activation of the oncogene and possible development of cancer. Pseudotyping Tropism dictates which...manufacturing. Molecular Therapy — Methods & Clinical Development , 28 , 116–128. https://doi.org/10.1016/j.omtm...

...Watanabe, M., Nishikawaji, Y., Kawakami, H., & Kosai, K. I. (2021). Adenovirus biology, recombinant adenovirus...verified, and linearized with the restriction enzyme PmeI . This construct is then transformed into AdEasier...cassette in one single viral particle. Vaccine Development rAdV vectors are highly immunogenic because they...

...PMID: 12663794 (Link opens in a new window) Kwon, I., & Schaffer, D. V. (2008). Designer gene delivery...be limited to small transgenes, enabling the development of further AAV applications. Read our blog post...opens in a new window) Merten, O. W. (2024). Development of stable packaging and producer cell lines for...